Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Fernandez-Del Castillo

Showing results (81-90 of 211) with videos related to

Pageof 22
Sort By:
Journal of the American College of Surgeons|July 26, 2015
Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic FindingsChristy E Cauley, Martha B Pitman, Jiahua Zhou, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 26, 2009
Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?Ioannis T Konstantinidis, Vikram Deshpande, Hui Zheng, et al.
Surgery|November 10, 2023
Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal AdenocarcinomaMaximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, et al.
The Oncologist|March 21, 2026
Disparities in the Diagnosis and Management of Exocrine Pancreatic Insufficiency in Resectable vs. Metastatic Pancreatic CancerPeiyun Ni, Christian Baglini, Jessica Meurer, et al.
Cytojournal|September 6, 2014
Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology GuidelinesMartha B Pitman, Barbara A Centeno, Syed Z Ali, et al.
Annals of Surgery|April 8, 2025
Efficacy of Neoadjuvant Therapy and the Prognostic Significance of Serum Carcinoembryonic Antigen Level in Patients with Localized Pancreatic Adenocarcinoma with Non-elevated Carbohydrate Antigen 19-9 LevelsGuoliang Qiao, Xiang Li, Marwa Mohamed, et al.
Annals of Surgery|December 11, 2025
Long-term Outcomes of Spleen-preserving Distal Pancreatectomy With or Without Preservation of Splenic Vessels: A Bi-institutional ExperienceShahrzad Arya, Marco Ventin, Liti Zhang, et al.
Annals of Surgery|July 2, 2024
Lymph Node Yield is Associated with Improved Overall Survival and Increased Time to Recurrence in Node-Negative Pancreatic Ductal Adenocarcinoma Following Neoadjuvant TherapyMaximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, et al.
Annals of Surgery|December 26, 2021
Underlying Bias in the Treatment of Pancreatic Cancer: Minorities Treated at the Same Facilities are Less Likely to Receive Neoadjuvant TherapyFidel Lopez-Verdugo, Zhi Ven Fong, Keith D Lillemoe, et al.
Surgery|February 23, 2023
Identification of high-risk features in mucinous cystic neoplasms of the pancreasMaximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, et al.
Pageof 22

Showing results (81-90 of 211) with videos related to

Sort By:
Pageof 22
Journal of the American College of Surgeons|July 26, 2015
Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic FindingsChristy E Cauley, Martha B Pitman, Jiahua Zhou, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 26, 2009
Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?Ioannis T Konstantinidis, Vikram Deshpande, Hui Zheng, et al.
Surgery|November 10, 2023
Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal AdenocarcinomaMaximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, et al.
The Oncologist|March 21, 2026
Disparities in the Diagnosis and Management of Exocrine Pancreatic Insufficiency in Resectable vs. Metastatic Pancreatic CancerPeiyun Ni, Christian Baglini, Jessica Meurer, et al.
Cytojournal|September 6, 2014
Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology GuidelinesMartha B Pitman, Barbara A Centeno, Syed Z Ali, et al.
Annals of Surgery|April 8, 2025
Efficacy of Neoadjuvant Therapy and the Prognostic Significance of Serum Carcinoembryonic Antigen Level in Patients with Localized Pancreatic Adenocarcinoma with Non-elevated Carbohydrate Antigen 19-9 LevelsGuoliang Qiao, Xiang Li, Marwa Mohamed, et al.
Annals of Surgery|December 11, 2025
Long-term Outcomes of Spleen-preserving Distal Pancreatectomy With or Without Preservation of Splenic Vessels: A Bi-institutional ExperienceShahrzad Arya, Marco Ventin, Liti Zhang, et al.
Annals of Surgery|July 2, 2024
Lymph Node Yield is Associated with Improved Overall Survival and Increased Time to Recurrence in Node-Negative Pancreatic Ductal Adenocarcinoma Following Neoadjuvant TherapyMaximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, et al.
Annals of Surgery|December 26, 2021
Underlying Bias in the Treatment of Pancreatic Cancer: Minorities Treated at the Same Facilities are Less Likely to Receive Neoadjuvant TherapyFidel Lopez-Verdugo, Zhi Ven Fong, Keith D Lillemoe, et al.
Surgery|February 23, 2023
Identification of high-risk features in mucinous cystic neoplasms of the pancreasMaximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, et al.
Pageof 22